Skip to Content
Merck

Involvement of leukotriene B4 in dermatophyte-related itch in mice.

Pharmacological reports : PR (2014-06-21)
Tsugunobu Andoh, Yusuke Takayama, Yasushi Kuraishi
ABSTRACT

Proteinase-activated receptor-2 (PAR2) is involved in dermatophyte-induced scratching and leukotriene B4 (LTB4) release from keratinocytes. We investigated whether PAR2-mediated LTB4 production is involved in dermatophyte-induced scratching. Dermatophyte extract was injected intradermally and scratching was observed in mice. LTB4 was determined by enzyme immunoassay. Dermatophyte extract-induced scratching was inhibited by zileuton (5-lipoxygenase inhibitor), ONO-4057 (LTB4 antagonist), FSLLRY-NH2 (PAR2 antagonist), and anti-PAR2 antibody. Dermatophyte extract injection increased the cutaneous content of LTB4, which was inhibited by zileuton and FSLLRY-NH2. These results suggest the involvement of LTB4 in dermatophyte-associated itch. LTB4 production might be due to PAR2 stimulation in the skin.

MATERIALS
Product Number
Brand
Product Description

USP
Indomethacin, United States Pharmacopeia (USP) Reference Standard
Supelco
Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Indomethacin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Indomethacin, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
Indomethacin, meets USP testing specifications
Supelco
Valeric acid, analytical standard
Sigma-Aldrich
Valeric acid, ≥99%, FCC, FG
Sigma-Aldrich
Valeric acid, ≥99%